International Stem Cell Corporation
ISCO
$0.115
$0.02527.78%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -293.71% | -595.65% | 12.64% | 60.42% | 149.65% |
| Total Depreciation and Amortization | 1.01% | -5.83% | -9.86% | -11.01% | -15.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.04% | 19.52% | 21.12% | 19.94% | 9.13% |
| Change in Net Operating Assets | 73.01% | -57.40% | -1,233.33% | 126.43% | -57.76% |
| Cash from Operations | -70.72% | -93.90% | -8.93% | 179.82% | 1,444.44% |
| Capital Expenditure | -106.25% | -115.15% | -356.25% | -7,900.00% | -627.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 57.14% | 60.00% | 70.00% | 80.00% |
| Cash from Investing | -106.02% | -98.63% | -196.15% | -654.55% | -219.23% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.10% | -111.56% | -18.72% | 48.16% | 374.53% |
